Published December 2019
| Version v1
Journal article
Research progress and clinical decision of internal mammary prophylactic radiotherapy after breast cancer surgery
Creators
- 1. Department of Radiation Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing (China)
Description
Although the internal mammary is the lymphatic drainage site for breast cancer, whether postoperative radiotherapy needs to be irradiated remains controversial. In recent years, several random studies have discussed internal mammary radiotherapy to varying degrees and no evidence has obtained that internal mammary radiotherapy bring clinical benefits to overall survival. In clinical practice, internal mammary prophylactic radiotherapy should maintain the balance among the risk of tumor recurrence, prescription dose and radiotherapy techniques to avoid the increased risk of radiotherapy-related death that offsets the possible survival benefits. (authors)
Additional details
Identifiers
Publishing Information
- Journal Title
- Chinese Journal of Radiation Oncology
- Journal Volume
- 28
- Journal Issue
- 12
- Journal Page Range
- p. 949-952
- ISSN
- 1004-4221
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 55022301
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BALANCES; DEATH; DOSES; DRAINAGE; HAZARDS; IRRADIATION; MAMMARY GLANDS; NEOPLASMS; RADIOTHERAPY; SURGERY
- Descriptors DEC
- BODY; DISEASES; GLANDS; MEASURING INSTRUMENTS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY; WEIGHT INDICATORS
Optional Information
- Notes
- 28 refs.; http://dx.doi.org/10.3760/cma.j.issn.1004-4221.2019.12.016